Esophageal and Gastric Cancers.

Authors

Anushna Sunila Babu, Mohammad Umar, Abass Alavi, Rakesh Kumar

Published in

PET clinics. Aug 01, 2026. Epub Aug 01, 2026.

Abstract

Esophageal and gastric cancers carry high mortality due to late-stage diagnosis, necessitating accurate staging and response assessment. Fluorine-18 fluorodeoxyglucose (¹⁸F-FDG) PET/computed tomography (CT) integrates metabolic and anatomic imaging, playing a pivotal role in detecting occult metastases, guiding therapy decisions, and assessing early treatment response. It is particularly effective in esophageal cancer and intestinal-type gastric adenocarcinoma, but has limited sensitivity in diffuse and mucinous subtypes. PET/CT enhances radiotherapy planning and distinguishes recurrence from post-treatment changes.

PMID:
42542387
Bibliographic data and abstract were imported from PubMed on 02 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.